Pfizer in Puurs develops potential vaccine for Bronchiolitis.
The American firm hopes to obtain marketing authorization for its candidate vaccine against RSV, the virus that causes bronchiolitis, by the fall. In Puurs, investments are planned so that the Belgian production plant can continue to keep pace. Article reserved for subscribers Journalist at the service of society By Anne-Sophie Leurquin Published on 03/20/2023 at … Read more